BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2021 8:38:05 AM | Browse: 553 | Download: 1162
 |
Received |
|
2021-01-26 14:57 |
|
Peer-Review Started |
|
2021-01-26 15:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-29 03:54 |
|
Revised |
|
2021-04-16 15:28 |
|
Second Decision |
|
2021-04-26 09:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-26 11:44 |
|
Articles in Press |
|
2021-04-26 11:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-19 00:52 |
|
Publish the Manuscript Online |
|
2021-05-20 08:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Role of modern radiotherapy in managing patients with hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou and Moon-Sing Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shih-Kai Hung, MD, PhD, Assistant Professor, Chief Doctor, Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2 Mingsheng Road, Dalin, Chia-Yi 62247, Taiwan. oncology158@yahoo.com.tw |
| Key Words |
Hepatocellular carcinoma; Stereotactic body radiotherapies; Radiotherapy; Guideline; Combined treatment; Immunotherapy |
| Core Tip |
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and treatments outcome are often unsatisfactory. The high post-monotherapy recurrence rate points to the need to combine modalities, including radiotherapy (RT). The international guidelines from North America, Europe and Asia offer treatment recommendations based on different classification systems. However, not all of these treatment guidelines include RT and the role of combined modalities. Hence, the present study reviewed clinical evidence of different combined modalities in managing HCC, focusing on RT's role and especially modern advanced RT techniques and the interaction with game-changing immunotherapy. |
| Publish Date |
2021-05-20 08:38 |
| Citation |
Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2434-2457 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i20/2434.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i20.2434 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
